CBAY

Cymabay Therapeutics

Delisted

CBAY was delisted on the 21st of March, 2024.

145 hedge funds and large institutions have $322M invested in Cymabay Therapeutics in 2020 Q4 according to their latest regulatory filings, with 46 funds opening new positions, 41 increasing their positions, 36 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
145
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$1.9M
Puts
$3.98M
Net Calls
Net Calls Change

Top Buyers

1 +$5M
2 +$4.88M
3 +$4.63M
4
Citadel Advisors
Citadel Advisors
Florida
+$1.73M
5
BlackRock
BlackRock
New York
+$1.47M

Top Sellers

1 -$12.4M
2 -$9.53M
3 -$8.63M
4
Norges Bank
Norges Bank
Norway
-$7.67M
5
SSA
Schonfeld Strategic Advisors
New York
-$3.63M
Name Holding Trade Value Shares
Change
Change in
Stake
1
$59.1M
2
$30.9M
3
$23M
4
$19.7M
5
$16.6M
6
$14.5M
7
$10.4M
8
$10.3M
9
$9.42M
10
$8.53M
11
$8.32M
12
$7.73M
13
$7.24M
14
$7.19M
15
$6.98M
16
$6.4M
17
$5.97M
18
$5.4M
19
$4.19M
20
$3.37M
21
$3.36M
22
$3.12M
23
$3.12M
24
$2.98M
25
$2.36M